Cadrenal Therapeutics, Inc. (CVKD) Tops Q3 EPS by 8c

Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) reported Q3 EPS of ($1.31), $0.08 better than the analyst estimate of ($1.39).

For earnings history and earnings-related data on Cadrenal Therapeutics, Inc. (CVKD) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• DA Davidson Reiterates Buy Rating on Criteo S.A. (CRTO) Amid Reports of M&A Interest
• Carlisle (CSL) PT Lowered to $340 at Truist on 'Input Cost Inflation'